ALS Limited (ASX:ALQ)

ALS Limited Revenue

In the fiscal year ending March 31, 2026, ALS Limited had annual revenue of 3.32B AUD with 10.69% growth. ALS Limited had revenue of 1.66B in the half year ending March 31, 2026, with 34.01% growth. That makes ALS Limited the 4,536th largest company in the world by revenue and 68th in Australia.

• Revenue: 3.32B
• Revenue Growth: +10.69%
• P/S Ratio: 3.09
• Revenue / Employee: 142.24K
• Employees: 23,342
• Market Cap: 10.25B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Life Sciences 2.03B 61.0%
• Commodities 1.29B 39.0%

By Geography

Chart

• EMENA (Europe, Middle East, North Africa) 1.17B 35.2%
• Americas 1.13B 33.9%
• Asia/Pacific 949.90M 28.6%
• Africa 74.80M 2.3%

Fiscal year ended Mar 31, 2026 See the full ALS Limited breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.32B	320.70M	10.69%
Mar 31, 2025	3.00B	537.80M	21.85%
Mar 31, 2024	2.46B	182.40M	8.00%
Mar 31, 2023	2.28B	327.40M	16.77%
Mar 31, 2022	1.95B	190.40M	10.81%

Data Source: S&P Global Market Intelligence Last updated: May 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 18, 2026

Data Sources Report a data error